Humanpro delivers 300+ premium functional ingredients across 8 categories—from amino acids to botanical extracts. We target diverse health benefit areas including nootropics and metabolism optimization to power global nutrition innovation.
Explore Ingredient PortfolioIntegrating localized tech and agile supply chains, we enable 7 application formats (tablets to softgels) via synthesis/fermentation/extraction processes. ISO-certified systems ensure ingredient stability, accelerating your product commercialization with science-driven precision.
Discover Manufacturing SolutionsWe offer end-to-end services: product development based on concept creation, formulation, and regulatory navigation. Leveraging our ingredient database and health segment expertise, we ensure compliance and market readiness, reducing time-to-market.
See our Customised ServicesHumanpro supplies high-bioavailability functional ingredients across diverse wellness sectors. From immune support and metabolic modulation to cognitive enhancement, we overcome stability and absorption barriers to enable science-backed precision nutrition products.
Rooted in China and synergizing cutting-edge R&D with global resources, we build vertically integrated supply chains from molecular design to worldwide delivery, ensuring uncompromising quality, stable supply, and traceable responsibility at every stage.

Humanpro also provides specialized manufacturing solutions: custom premixes, contract manufacturing, and advanced tech industrialization. Our vertically integrated systems ensure efficient production and flexible supply from formulation to market, accelerating product innovation.

Humanpro delivers specialized nutritional premix customization and market-ready blend manufacturing, accelerating product launch with scientifically controlled solutions for differentiated brand growth.

Humanpro delivers end-to-end nutritional OEM solutions. Leveraging scalable full-chain capacity and scientifically controlled systems, we provide flexible supply and innovative development capabilities to be your trusted partner for quality-focused satisfaction.

Powered by core technologies: Co-loaded liposomal delivery, sustained-release systems, microencapsulation, and particle engineering (micronization/agglomeration/coating)—Humanpro transform scientific innovations into scalable solutions.
Explore the latest news and insights from Humanpro, including industry trends, event updates and customer case studies.

In the field of SARMs research, molecular structure optimization is a key pathway to enhancing compound performance and applicability. RAD150 (an esterified variant of RAD140) and ACP-105 represent two classes of structurally modified featured compounds. The former improves pharmacokinetic properties through an esterification strategy, while the latter stands out for its high selectivity in muscle and prostate safety studies. Humanpro is committed to providing these scientifically optimized research tools to help researchers conduct more precise mechanistic exploration and model development.

In the pharmaceutical and biomedical research fields, clinical frontier SARMs (such as PF-06260414, GSK-2881078, and GLPG0492), as selective androgen receptor modulators that have entered clinical trials, represent potential breakthroughs in treating muscle wasting and metabolic diseases. Humanpro is committed to supplying the highest purity cutting-edge research materials, supporting your innovative R&D projects and facilitating the transition from lab to clinic.

In the field of anabolic research, non-steroidal Selective Androgen Receptor Modulators (SARMs) have attracted significant attention due to their potential tissue selectivity. The AC series SARMs, such as AC-262536 and AC-262,356, represent a new generation of research compounds designed to explore the mechanisms of muscle growth and strength enhancement while minimizing the side effects associated with traditional androgen therapies. Humanpro supplies high-purity AC series raw materials, providing reliable support for your preclinical research and drug development projects.


